ImmunoVEX HSV2Alternative Names: Genital herpes vaccine - BioVex; Herpes simplex virus vaccine - BioVex
Latest Information Update: 19 Mar 2011
At a glance
- Originator BioVex
- Class Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Phase I Herpes simplex virus infections
Most Recent Events
- 04 Mar 2011 BioVex has been acquired by Amgen
- 05 Mar 2010 Phase-I clinical trials in Herpes simplex virus infections prevention in United Kingdom (Parenteral)